In order to fully understand the effect of ADT on stromal AR action in prostate cancer progression and CRPC development, more in-depth analyses should be carried out using clinically relevant clinical cohorts and datasets to assess cellular and molecular changes in both epithelial and stromal compartments. The gene discussed is AR; the disease is Familial prostate cancer.